Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12419963
Diels-Alder conjugation methods
granted -
US 12421317
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
granted -
US 12421315
CLL-1 targeted immunotherapies
granted -
US 12421512
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
granted -
US 12415856
EGFR x CD28 multispecific antibodies
granted -
US 12410442
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
granted -
US 12402611
Genetically modified mice and engraftment
granted -
US 12404505
Delivery of a gene-editing system with a single retroviral particle and methods of generation and use
granted -
US 12396444
Mouse comprising a humanized TRKB locus
granted -
US 12397028
Adoptive cellular therapy
granted -
US 12396952
Tuning of release kinetics in hydrogels
granted -
US 12398212
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 12391753
Antigen binding molecule formats
granted -
US 12389889
Mouse having a humanized cluster of differentiation 47 gene
granted -
US 12391920
Models of tauopathy
granted -
US 12391734
PD-1 homing endonuclease variants, compositions, and methods of use
granted -
US 12378557
Treatment of sepsis with PCSK9 and LDLR modulators
granted -
US 12377159
Steroids and protein-conjugates thereof
granted -
US 12378258
Biologically active molecules, conjugates thereof, and therapeutic uses
granted -
US 12370257
Materials and methods of treating MHC-I-opathy risk haplotypes
granted -
US 12371503
Methods of treatment using a leptin receptor agonist antibody
granted -
US 12365711
TGFβ signal convertor
granted -
US 12350318
Combination therapy to treat brain cancer
granted -
US 12350374
Fabrication of protein-encapsulating microgels
granted